Charles Bhatt

Charles Bhatt has built his career at Dana-Farber Cancer Institute, one of the most innovative cancer research institutions in the world and the birthplace of modern pediatric oncology and multiple blood cancer therapies. His research has contributed to the understanding and treatment of hematologic malignancies including lymphoma, leukemia, and multiple myeloma through clinical and translational studies. He has been involved in the development and evaluation of novel immunotherapeutic and targeted approaches that have become standard of care in blood cancers. His work reflects the Dana-Farber tradition of transforming cancer biology into lifesaving treatments.